David Banach
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Clostridium difficile and Clostridium perfringens research 6
- Viral Infections and Outbreaks Research 5
- Epidemiology 18
- Co-authors
- Thomas M. Moran (2 shared papers)Cheryl R. Stein (2 shared papers)David P. Calfee (4 shared papers)Changchun Liu (5 shared papers)Ziyue Li (4 shared papers)Lori Avery (5 shared papers)Gonzalo Bearman (3 shared papers)L. Silvia Muñoz-Price (3 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (16 papers)American Journal of Infection Control (3 papers)Open Forum Infectious Diseases (3 papers)Current Infectious Disease Reports (2 papers)Blood (1 paper)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
David Banach
39 papers receiving 922 citations
David Banach's Hit Papers
Peers
Comparison fields: 5 of 102
- Applied Microbiology and Biotechnology 97
- Molecular Medicine 156
- Infectious Diseases 277
- Epidemiology 481
- Clinical Biochemistry 81
Countries citing papers authored by David Banach
This map shows the geographic impact of David Banach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Banach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Banach more than expected).
Fields of papers citing papers by David Banach
This network shows the impact of papers produced by David Banach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Banach. The network helps show where David Banach may publish in the future.
Co-authors
The 25 scholars most cited alongside David Banach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 214 | |
| 2 | 2013 | 135 | |
| 3 | 2012 | 89 | |
| 4 | 2011 | 60 | |
| 5 | 2018 | 50 | |
| 6 | Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a Hit paper breakdown → | 2024 | 48 |
| 7 | 2023 | 44 | |
| 8 | 2015 | 39 | |
| 9 | 2017 | 28 | |
| 10 | 2015 | 25 | |
| 11 | 2016 | 23 | |
| 12 | 2020 | 17 | |
| 13 | 2021 | 17 | |
| 14 | 2011 | 17 | |
| 15 | 2013 | 17 | |
| 16 | 2021 | 14 | |
| 17 | 2024 | 13 | |
| 18 | 2012 | 13 | |
| 19 | 2011 | 12 | |
| 20 | 2016 | 11 |
About David Banach
David Banach is a scholar working on Infectious Diseases, Epidemiology, Clinical Biochemistry, Pulmonary and Respiratory Medicine and Molecular Medicine, having authored 48 papers that have together received 952 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (8 papers), Antibiotic Use and Resistance (7 papers), Antibiotic Resistance in Bacteria (7 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Infection Control and Ventilation (5 papers), Disaster Response and Management (5 papers), Viral Infections and Outbreaks Research (5 papers) and Nosocomial Infections in ICU (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (97 citations), Molecular Medicine (156 citations), Infectious Diseases (277 citations), Epidemiology (481 citations) and Clinical Biochemistry (81 citations). David Banach has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Thomas M. Moran, Cheryl R. Stein, David P. Calfee, Changchun Liu, Ziyue Li, Lori Avery, Gonzalo Bearman, L. Silvia Muñoz-Price, Florian Krammer and Gene S. Tan. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Open Forum Infectious Diseases, Current Infectious Disease Reports and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.